Amphotericin B-induced nephrogenic diabetes insipidus.
Ishikawa
San-e
SE
D000666:Amphotericin B / Q000009:adverse effects* / Q000627:therapeutic use; D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018500:Diabetes Insipidus, Nephrogenic / Q000097:blood / Q000139:chemically induced*; D006801:Humans; D007685:Kidney Tubules, Collecting / Q000187:drug effects / Q000378:metabolism; D009181:Mycoses / Q000188:drug therapy; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism
D000935:Antifungal Agents; D000666:Amphotericin B; D012964:Sodium; D011188:Potassium